UCSF’s Dr. Susan Desmond-Hellmann is profiled in the Sunday, April 11, 2010 issue of the San Francisco Chronicle. The story is featured on the front page.
CNBC’s Mike Huckman looks back at pharma’s biggest decade, and also looks ahead at what’s to come in today’s segment “Big Pharma’s Big Decade.” UCSF’s Chancellor Dr. Susan Desmond-Hellmann is featured in the program. Dr. Desmond-Hellmann who brought the world’s anti-cancer blockbuster drugs to market says what she’s “most proud of is that we changed the way people think about cancer.”
2010 could be a year of firsts– the first therapeutic vaccine for prostate cancer, first Lupus drug, first once a week drug to treat diabetes, and the first new flu vaccine technology since the 1950’s.
According to Dr. Desmond-Hellmann, “what is tremendous is how there is literally an explosion of biology – it should be a golden era.” She also believes that there could be a significant break-through in Alzheimer’s disease on the horizon. Drugs today just treat the symptoms but don’t slow the progression.
Dr. Desmond-Hellmann concludes by saying: “If there was a genuine breakthrough in Alzheimer’s we’re talking about the kinds of medicines that could be the biggest products in the world… bigger than Lipitor and Avastin… from a business perspective this could be huge.”
Watch the video here.
UCSF Chancellor Susan Desmond-Hellmann is featured in the CNBC's special "Biopharma: 10 Years in the Making." Watch the segment here: